InsiderDB

Lobbying disclosures · Lobbying report

MRNA: second_quarter 2026 lobbying report

Vaccine Policy, FDA Vaccine Approvals

Follow MRNA
Became public
Jul 16, 2026, 2:17 PM EDT
Event / period date
Not stated
Collected
Nov 9, 2026, 11:28 PM EST

Why this is connected

Exact legal-name match: Moderna, Inc. (https://www.sec.gov/Archives/edgar/data/1682852/).

Reported lobbying amounts

Expenses: $290,000.00

These are different reporting measures. They are not added together or treated as spending on one particular bill.

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/c89b7493-c789-4845-8a01-bf0334227f23/","filing_uuid":"c89b7493-c789-4845-8a01-bf0334227f23","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/c89b7493-c789-4845-8a01-bf0334227f23/print/","filing_document_content_type":"text/html","income":null,"expenses":"290000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Jennie Unger Skelton","dt_posted":"2026-07-16T14:17:49-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"28 Liberty Ship Way","registrant_address_2":"Suite 2815","registrant_different_address":false,"registrant_city":"Sausalito","registrant_state":"CA","registrant_zip":"94965","registrant":{"id":401107958,"url":"https://lda.gov/api/v1/registrants/401107958/","house_registrant_id":56260,"name":"MODERNA, INC.","description":null,"address_1":"28 Liberty Ship Way","address_2":"Suite 2815","address_3":null,"address_4":null,"city":"Sausalito","state":"CA","state_display":"California","zip":"94965","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JENNIE U SKELTON","contact_telephone":"+1 415-903-2800","dt_updated":"2026-07-24T13:17:58.779813-04:00"},"client":{"id":57657,"url":"https://lda.gov/api/v1/clients/57657/","client_id":57657,"name":"MODERNA, INC.","general_description":"Pharmaceuticals","client_government_entity":null,"client_self_select":true,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2023-10-31"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Vaccine Policy, FDA Vaccine Approvals","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151608,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"CURTIS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144626,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"LEPORE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Price change after we could observe it

-6.97% MRNA

Adjusted closing prices from Nov 11, 2026 to Nov 12, 2026. SPY changed -0.35% over the same dates. The start is the first available close after both publication and collection. This is a price comparison, not an executed trade, investor profit, or a backtested strategy.

Congressional trading in MRNA

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.